Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): Role of GABAA receptor subtypes

[1]  N. Ator,et al.  Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acidA/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023 , 2008, Pharmacology Biochemistry and Behavior.

[2]  Stephanie C. Licata,et al.  Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond , 2008, Pharmacology Biochemistry and Behavior.

[3]  N. Mirza,et al.  Comparative Cue Generalization Profiles of L-838, 417, SL651498, Zolpidem, CL218,872, Ocinaplon, Bretazenil, Zopiclone, and Various Benzodiazepines in Chlordiazepoxide and Zolpidem Drug Discrimination , 2006, Journal of Pharmacology and Experimental Therapeutics.

[4]  C. France,et al.  Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys , 2006, British journal of pharmacology.

[5]  G. Dawson,et al.  Evidence for a Significant Role of α3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines , 2005, The Journal of Neuroscience.

[6]  William J. A. Eiler,et al.  Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol. , 2005, Alcoholism, clinical and experimental research.

[7]  R. Spealman,et al.  Intravenous Self‐Administration Techniques in Monkeys , 2005, Current protocols in neuroscience.

[8]  R. Spealman,et al.  Contribution of α1GABAA and α5GABAA Receptor Subtypes to the Discriminative Stimulus Effects of Ethanol in Squirrel Monkeys , 2005, Journal of Pharmacology and Experimental Therapeutics.

[9]  G. Dawson,et al.  Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABAA receptors , 2005 .

[10]  G. Dawson,et al.  Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Ator.  Contributions of GABAA Receptor Subtype Selectivity to Abuse Liability and Dependence Potential of Pharmacological Treatments for Anxiety and Sleep Disorders , 2005, CNS Spectrums.

[12]  M. Weiss,et al.  Effect of Flumazenil on GABAA Receptors in Isolated Rat Hippocampal Neurons , 2002, Neurochemical Research.

[13]  Joris C Verster,et al.  Effects of Alprazolam on Driving Ability, Memory Functioning and Psychomotor Performance: A Randomized, Placebo-controlled Study , 2002, Neuropsychopharmacology.

[14]  F. Kuenzi,et al.  Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor , 2002, The Journal of Neuroscience.

[15]  G. Dawson,et al.  3-Heteroaryl-2-pyridones: Benzodiazepine Site Ligands with Functional Selectivity for α2/α3-Subtypes of Human GABAA Receptor-Ion Channels , 2002 .

[16]  R. Spealman,et al.  Role of GABAA/benzodiazepine receptors containing α1 and α5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys , 2002, Psychopharmacology.

[17]  R. Spealman,et al.  Isobolographic analysis of chlordiazepoxide and triazolam combinations in squirrel monkeys discriminating triazolam , 2001, Psychopharmacology.

[18]  U. Rudolph,et al.  GABA(A) receptor subtypes: dissecting their pharmacological functions. , 2001, Trends in pharmacological sciences.

[19]  R. Spealman,et al.  Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs , 2001, Psychopharmacology.

[20]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[21]  R. Spealman,et al.  Transduction of the discriminative stimulus effects of zolpidem by GABAA/α1 receptors , 2000 .

[22]  C. France,et al.  Antagonism of the discriminative stimulus effects of positive γ-aminobutyric acid(A) modulators in rhesus monkeys discriminating midazolam , 2000 .

[23]  R. Spealman,et al.  Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines. , 2000, Experimental and clinical psychopharmacology.

[24]  R. Mckernan,et al.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.

[25]  R. Baker,et al.  Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. , 2000, Experimental and clinical psychopharmacology.

[26]  R. Spealman,et al.  Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  J. Benson,et al.  Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.

[28]  N. Ator.  High-Dose Discrimination Training with Midazolam Context Determines Generalization Profile , 1999, Pharmacology Biochemistry and Behavior.

[29]  C. France,et al.  Discriminative-stimulus effects of triazolam and midazolam in rhesus monkeys. , 1999, Behavioural pharmacology.

[30]  W. Wisden,et al.  GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands. , 1997, Annals of medicine.

[31]  P. Whiting,et al.  Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors. , 1993, Molecular pharmacology.

[32]  J. Kemp,et al.  Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. , 1993, Molecular pharmacology.

[33]  W. Haefely,et al.  Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. , 1992, The Journal of pharmacology and experimental therapeutics.

[34]  H. Shannon,et al.  Beta-carbolines as antagonists of the discriminative stimulus effects of diazepam in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[35]  R. Spealman.  Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788. , 1985, The Journal of pharmacology and experimental therapeutics.

[36]  Stephanie C. Licata,et al.  Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors , 2005, Psychopharmacology.

[37]  G. Dawson,et al.  Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors. , 2005, British journal of pharmacology.

[38]  R. Spealman,et al.  Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABAA/α1 receptors , 2002, Psychopharmacology.

[39]  J. Benson,et al.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. , 1999, Nature.

[40]  S. Enna.  Current protocols in pharmacology , 1998 .

[41]  R. Griffiths,et al.  Asymmetrical cross‐generalization in drug discrimination with lorazepam and pentobarbital training conditions , 1989 .

[42]  W. Haefely.  The preclinical pharmacology of flumazenil. , 1988, European journal of anaesthesiology. Supplement.